Permanent neonatal diabetes: combining sulphonylureas with insulin may be an effective treatment
<p>Background: Permanent neonatal diabetes caused by mutations in the KCNJ11 gene may be managed with high‐dose sulfonylureas. Complete transfer to sulfonylureas is not successful in all cases and can result in insulin monotherapy. In such cases, the outcomes of combining sulfonylureas with in...
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Journal article |
| Gepubliceerd in: |
Wiley
2018
|